New Drugs for Patients With Multiple Sclerosis
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. John Richert discusses 6 approved drugs that have changed the lives of the young patients who have this disabling disease. The early diagnosis of multiple sclerosis and the prompt institution of therapy is beginning to show dividends in that the disease does not progress as rapidly.
Overview
Dr. John Richert discusses 6 approved drugs that have changed the lives of the young patients who have this disabling disease. The early diagnosis of multiple sclerosis and the prompt institution of therapy is beginning to show dividends in that the disease does not progress as rapidly.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
mIDH Gliomas Explained: Characteristics and Management Strategies
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?